Dramatic AIDS Death Decline Is Extraordinary Return on InvestmentStatement by Daniel Zingale
Executive Director, AIDS Action October 7, 1998 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!
Contact:media@aidsaction.org
or call: 202-986-1300
While our investment in AIDS care and research is paying off, our divestment from HIV prevention is creating a new epidemic for a new generation of Americans. Epidemiological and anecdotal evidence point to a disturbing increase in unsafe activity among at-risk populations, particularly young people. Indeed, half of the 40,000 new HIV infections every year are among people under 25. Today's extraordinary news about the success of new drugs contrasts with the fact that they're being denied to an entire class of Americans. It is a tragedy that current federal policy denies low-income HIV-positive Americans access to Medicaid and AIDS-preventing drugs until they develop AIDS. Medicaid must be modernized to ensure that all HIV-positive individuals get access to drug treatment and medical care before AIDS sets in, not after. The same vigilance and determination that brought about these dramatic new death rates must be maintained so that we can provide care for every American, prevention for everyone at risk and ultimately, a genuine end to AIDS. A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! This article was provided by AIDS Action Council.
|
|